XML 22 R9.htm IDEA: XBRL DOCUMENT
v3.21.2

Nature of Operations and Liquidity | 6 Months Ended
--- | ---
Jun. 30, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract] |
Nature of Operations and Liquidity |
1. | Nature of Operations and Liquidity
Catalyst Biosciences, Inc. and its subsidiary (the “Company” or “Catalyst”) is a fully integrated research and clinical development biopharmaceutical company with expertise in protease engineering, discovery, translational research, clinical development, and manufacturing. The Company is focused on advancing its protease product candidates in the fields of hemostasis and complement regulation. The Company is located in South San Francisco, California and operates in one segment. The Company had a net loss of $42.4 million for the six months ended June 30, 2021 and an accumulated deficit of $357.1 million as of June 30, 2021. The Company expects to continue to incur losses for the next several years. As of June 30, 2021, the Company had $86.5 million of cash, cash equivalents and short-term investments. Its primary uses of cash are to fund operating expenses, including research and development expenditures and general and administrative expenditures. Based on the current status of its research and development plans, the Company believes that its existing cash, cash equivalents and short-term investments as of June 30, 2021 will be sufficient to fund its cash requirements for at least the next 12 months from the date of the filing of this quarterly report. If, at any time, the Company’s prospects for financing its research and development programs decline, the Company may decide to reduce research and development expenses by delaying, discontinuing or reducing its funding of one or more of its research or development programs. Alternatively, the Company might raise funds through strategic collaborations, public or private financings or other arrangements. Such funding, if needed, may not be available on favorable terms, or at all.

X
- Definition Nature of operations and liquidity. + References No definition available. + Details
Name: | cbio_NatureOfOperationsAndLiquidityTextBlock
Namespace Prefix: | cbio_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration